Pharmaceutical Lifecycle Management

1
Pharmaceutical LifecycleManagement
2
Summary

• "Pharmaceutical Lifecycle Management Strategies
  in 2017" provides acomprehensive assessment of
  product lifecycle (LCM) management strategies
  thatare being implemented by pharmaceutical
  companies around the world. Thepharmaceutical
  industry remains highly competitive and
  lucrative, and companiesare investing
  significant time and resources into implementing
  strategies aimed atpreserving the revenue
  streams of their products by extending patent
  life, delayingcompetition or slowing the pace of
  revenue loss following the end of
  marketexclusivity.
• The study, delivered in the form of an 82-slide
  PowerPoint presentation investigates a wide range
  of commercial, developmental, legal and
  regulatory strategies. Thisreport format allows
  you to easily assemble high-quality presentations
  and research material to meet a variety of
  corporate requirements. Our research deep dives
  intothe rationale for implementing LCM
  strategies, as well as the challenges, risks
  andcommercial opportunities they represent.

3
(No Transcript)
4

• Moreover, detailed case studies showcasing recent
  real-world examples of LCMstrategies will enable
  understanding of the key factors that determined
  their success. Information leveraged from our
  robust industry-leading database also
  highlightsstrategies being implemented for
  products currently in development.
• The pharmaceutical industry will continue to face
  a wide range of challenges in the coming years,
  including patent cliffs, declining productivity,
  intensifying levels ofcompetition from generic
  and biosimilar manufacturers, low reimbursement
  levelsand stricter regulatory policies. Careful
  LCM planning will continue to be a crucial
  element of the industrys ability to answer these
  problems.
• Research conducted extensive research to provide
  a comprehensive understandingof the LCM
  strategies being implemented by players in the
  pharmaceutical industry. This new report adds to
  our unique portfolio of trusted industry analyses
  that enable our clients to assess the most
  promising commercial areas in the market and
  exploit key business opportunities.

5
Scope

• What is driving the need for effective LCM
  strategies in the pharmaceuticalindustry?
• What are the most common LCM strategies being
  implemented?
• What are the business opportunities and
  commercial rewards arising from
  theimplementation of LCM strategies?
• What are the key factors that impact the choice
  of LCM strategy?
• What strategies have Big Pharma companies
  implemented in recent years topreserve revenues
  and market share?

6
Reasons to buy

• This report will allow you to -
• Gain insights into the rationale for implementing
  LCM strategies, alongside their key challenges,
  risks and potential benefits.
• Understand the key challenges that the
  pharmaceutical industry has been facingin recent
  years.
• Assess real-world examples of successful
  strategies implemented in the past, and the key
  factors that determined their success.
• Obtain information on strategies for products
  currently in development.

7
Full Reports
Pharmaceutical LifecycleManagement
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Emailpoonam_at_bharatbook.com Ou
r Bloghttps//www.bharatbook.com/blog/ Twitterht
tps//twitter.com/researchbook Facebookhttps//ww
w.facebook.com/BharatBook3B LinkedInhttp//www.li
nkedin.com/company/bharat-book-bureau
8
THANK YOU